DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.68, $0.17 worse than the analyst estimate of $0.85. Revenue for the quarter came in at $698.2 million versus the consensus estimate of $696.47 million.

GUIDANCE:

DexCom sees FY2022 revenue of $2.82-2.94 billion, versus the consensus of $2.96 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.